Kura jumps after positive data from blood cancer treatment trial
30/01/2024 15:50
** Shares of Kura Oncology KURA.O rise 14% to a record
high of $21.28
** Co says treatment with its drug ziftomenib showed 100%
complete remission of cancer in newly diagnosed patients in an
early-stage trial
** Says the drug is being evaluated in combination with
standard of care for the treatment of acute myeloid leukemia, a
type of blood cancer
** Up to last close, stock was up 41.2% in the last 12
months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))